| Common name: | |
| Defline: | (1 of 1) PTHR11289:SF0 - BREAST CANCER TYPE 2 SUSCEPTIBILITY PROTEIN |
| Description: | |
| Synonyms: | g13949.t1 |
| Chromosome: | chromosome 13 |
We did not create a plasmid for this gene.
We did not determine any protein-protein interactions for this gene.
| Insertion Junction | Mutant Strain | Insertion Junction Feature | Confidence (%) | Genome Version |
|---|---|---|---|---|
| CLIP2.012825_1 | CLIP2.012825 | CDS | 80 | 6.1 |
| CLIP2.012825_2 | CLIP2.012825 | CDS | 80 | 6.1 |
| CLIP2.014501_3 | CLIP2.014501 | CDS | 80 | 6.1 |
| CLIP2.014501_4 | CLIP2.014501 | CDS | 80 | 6.1 |
| CLIP2.021726_1 | CLIP2.021726 | CDS | 80 | 6.1 |
| CLIP2.021726_2 | CLIP2.021726 | CDS | 80 | 6.1 |
| CLIP2.027488_1 | CLIP2.027488 | CDS | 80 | 6.1 |
| CLIP2.027488_2 | CLIP2.027488 | CDS | 80 | 6.1 |
| CLIP2.053475_1 | CLIP2.053475 | CDS | 80 | 6.1 |
| CLIP2.053475_2 | CLIP2.053475 | CDS | 80 | 6.1 |
| LMJ.RY0402.056077_1 | LMJ.RY0402.056077 | CDS | 73 | 5.5 |
| LMJ.RY0402.064829_1 | LMJ.RY0402.064829 | intron | 73 | 5.5 |
| LMJ.RY0402.101267_1 | LMJ.RY0402.101267 | intron | 95 | 5.5 |
| LMJ.RY0402.101267_2 | LMJ.RY0402.101267 | intron | 95 | 5.5 |
| LMJ.RY0402.106574_1 | LMJ.RY0402.106574 | intron | 58 | 5.5 |
| LMJ.RY0402.153178_2 | LMJ.RY0402.153178 | CDS | 73 | 5.5 |
| LMJ.RY0402.203319_2 | LMJ.RY0402.203319 | 5'UTR_intron | 73 | 5.5 |
| PFAM: | PF09103, PF09169 |
| PANTHER: | PTHR11289 PTHR11289:SF0 |
| KEGG_ec: | |
| KEGG_orthology: | K08775 |
| KOG: | |
| Gene ontology terms:: | GO:0000724, GO:0006281 |
| Best arabidopsis TAIR name: | AT5G01630.1 |
| Best arabidopsis TAIR symbol: | ATBRCA2(V),BRCA2(V),BRCA2B |
| Best arabidopsis TAIR defline: | BRCA2-like B |
| Phytozome Locus Page |
Mutants in this gene exhibit a phenotype under the following conditions:
| Cisplatin, screen 1 of 4 ( 98% confidence (FDR = 0.02)) |
| Cisplatin, screen 2 of 4 ( 99% confidence (FDR = 0.0041)) |
| Cisplatin, screen 3 of 4 ( 99% confidence (FDR = 0.00038)) |
| Cisplatin, screen 4 of 4 ( 99% confidence (FDR = 0.0012)) |
| Methyl methanesulfonate, screen 3 of 4 ( 99% confidence (FDR = 0.00078)) |
| Methyl methanesulfonate, screen 4 of 4 ( 99% confidence (FDR = 0.00064)) |
| Zeocin, screen 5 of 5 ( 90% confidence (FDR = 0.093)) |
Note: FDR indicates the likelihood that a particular genotype-phenotype relationship is incorrect. Not all mutants in a particular gene show the same phenotype. Please see the mutant pages for each mutant's phenotypes. Complementation is needed to definitively prove a genotype-phenotype link. These data are from a pooled phenotyping experiment.
If you reference the phenotypic data above in a manuscript, please cite: Fauser et al. 2022 Nature Genetics.